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Type III secretion systems (T3SS) are dedicated to targeting anti-host effector proteins
into the cytosol of the host cell to promote bacterial infection. Delivery of the effectors
requires three specific translocator proteins, of which the hydrophilic translocator, LcrV,
is located at the tip of the T3SS needle and is believed to facilitate insertion of the
two hydrophobic translocators into the host cell membrane. Here we used Yersinia
as a model to study the role of LcrV in T3SS mediated intracellular effector targeting.
Intriguingly, we identified N-terminal lcrV mutants that, similar to the wild-type protein,
efficiently promoted expression, secretion and intracellular levels of Yop effectors, yet
they were impaired in their ability to inhibit phagocytosis by J774 cells. In line with this,
the YopH mediated dephosphorylation of Focal Adhesion Kinase early after infection was
compromised when compared to the wild type strain. This suggests that the mutants are
unable to promote efficient delivery of effectors to their molecular targets inside the host
cell upon host cell contact. The significance of this was borne out by the fact that the
mutants were highly attenuated for virulence in the systemic mouse infection model. Our
study provides both novel and significant findings that establish a role for LcrV in early
targeting of effectors in the host cell.
Keywords: LcrV, type III secretion system, YopH, translocation, pore formation, Yersinia pseudotuberculosis,
virulence
INTRODUCTION
Type Three Secretion systems (T3SS) were discovered more than 25 years ago when it was
established that Yersinia spp. targeted virulence proteins (effectors) into eukaryotic cells through
a delivery mechanism that required close bacteria-host cell contact (Rosqvist et al., 1991, 1994;
Sory and Cornelis, 1994). The T3SS require the coordination of more than 20 genes to promote
expression and secretion of the virulence proteins from the bacterium (Galán and Wolf-Watz,
2006).
Over the years, T3SS have been described in a wide variety of gram negative pathogens. While
some of them, such as Salmonella spp. and Shigella spp., use their T3SS to promote uptake by host
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cells (Finlay et al., 1988; Sasakawa et al., 1988, 1989; Elsinghorst
et al., 1989), in other pathogens such as Yersinia spp. and
Pseudomonas spp., the T3SS act to block uptake (Rosqvist et al.,
1988; Frithz-Lindsten et al., 1997). These opposing outcomes are
ascribed to the specific enzymatic activities and corresponding
molecular targets of the translocated effectors, rather than the
actual T3SS structure and function that is overall well conserved
(Rosqvist et al., 1995; Frithz-Lindsten et al., 1997, 1998; Akopyan
et al., 2011).
The injection model is widely used to explain the mode of
function of the T3SS. It dictates that protein translocation occurs
in one step from the bacterial cytosol to the target-cell cytoplasm
through a conduit created by the basal body and a needle-like
hollow tube that is extended by a tip complex that forms a
pore in the host cell membrane (Galán and Wolf-Watz, 2006).
While there is evidence from recent elegant studies that the T3SS
substrates are indeed secreted through the narrow hollow needle
complex (Dohlich et al., 2014; Radics et al., 2014), there is to date
no direct experimental evidence that effectors secreted via the
needle are subsequently targeted directly into the host cell. On
the contrary, a recent study showed that effectors exogenously
added to the bacterial surface of both Yersinia and Salmonella
could be translocated in a T3SS-dependentmanner, suggesting an
alternative mechanism to the one-step injection model (Akopyan
et al., 2011).
The secreted substrates can be divided into two functional
classes; effectors and translocators. The effectors are delivered
into the target cell where they elicit a specific biological response.
Yersinia is an extracellular pathogen that replicates in the
lymphatic tissues of the host (Hanski et al., 1989; Simonet et al.,
1990). As such, Yersinia needs to be able to block phagocytosis
by the host immune cells such as macrophages, and the effector
YopH is essential for this event (Rosqvist et al., 1988; Fahlgren
et al., 2009). Phagocytosis is preceded by formation of focal
adhesion sites, which occurs at the cytoplasmic side of the host
cell membrane. Since phagocytosis is a rapid process with an
onset immediately after the establishment of bacteria-cell contact,
translocation and targeting of the effectors must essentially
occur instantly. Consistent with this, studies have shown that
YopH is translocated and targeted to the intracellular focal
adhesion sites within minutes after target cell contact (Andersson
et al., 1996, 1999; Persson et al., 1999), and that the T3SS
substrate YopK is involved in YopH targeting to the focal
adhesion sites (Thorslund et al., 2011; Dewoody et al., 2013).
The translocators facilitate the delivery of effectors across the
plasma membrane (Rosqvist et al., 1994; Sory and Cornelis, 1994;
Håkansson et al., 1996; Pettersson et al., 1999). The T3SS encode
three functionally conserved translocator proteins, two that are
generally hydrophobic and one that is hydrophilic (Matteï et al.,
2011). A key signature of the hydrophobic translocators is
their putative membrane spanning domain(s), suggesting that
they may target host membranes. Indeed, in Yersinia spp. the
hydrophobic translocators, YopB, and YopD, have been shown
to insert into erythrocyte membranes and induce pore formation
(Rosqvist et al., 1994; Sory and Cornelis, 1994). LcrV, the
hydrophilic translocator, localizes at the tip of the needle complex
(Mueller et al., 2005). LcrV facilitates insertion of YopB and
YopD in host cell membranes (Broz et al., 2007) and has been
proposed to promote translocation by serving as a pore-forming
platform. In addition, LcrV also has a role in regulation of yop
expression since deletion of lcrV results in down-regulated Yop
production (Price et al., 1991; Pettersson et al., 1999).
We have previously shown that LcrV secretion levels
correlates to in vivo virulence of Yersinia (Bröms et al., 2007).
As for other T3SS substrates, the very N-terminal region of
LcrV is somehow recognized by the secretion system and, thus,
mutants impaired for secretion have been mapped to the N-
terminal region (Bröms et al., 2007). Interestingly, introduction
of frame-shift mutations that completely changed the coding
sequence of the extreme N-terminal of LcrV, affected neither
LcrV secretion nor overall expression/secretion of other Yop
proteins. These LcrV mutants also induced YopE mediated
cytotoxicity in infected HeLa cells to the same extent as the
isogenic wild type strain (Bröms et al., 2007). In this study, we
performed a more in depth analysis of the N-terminal mutant
strains and could hereby show a novel role for the N-terminal
region of LcrV in the early targeting of Yop effectors, and
the corresponding ability of Yersinia to block phagocytosis by
macrophages and promote virulence in mice.
RESULTS
To study the role of LcrV in translocation we decided to utilize
two previously characterized in-cis N-terminal mutants of LcrV
(Bröms et al., 2007). These mutants contain +1 or −1 frame-
shift mutations, specifically altering the sequence of the first 15
amino acids, but leaving the remaining protein sequence intact
(Figure S1) and will hereafter be referred to as LcrV+1 and
LcrV−1 respectively. Importantly, both mutants exhibit intact
Yop-regulation, which is a prerequisite tomeaningfully study any
other role of LcrV.
The LcrV N-Terminus Is Important for Pore
Formation in Erythrocytes
Previous studies have established a strong correlation between
functional T3SS-mediated translocation and the ability to induce
pore formation as measured by hemolytic activity in infected
erythrocytes (Håkansson et al., 1996; Holmstrom et al., 1997;
Neyt and Cornelis, 1999; Olsson et al., 2004; Ryndak et al.,
2005). When the LcrV+1 and LcrV−1 strains were used to infect
erythrocytes they were essentially unable to induce any significant
hemolytic activity (Figure 1). In fact, the levels of hemolysis were
found to be similar to that induced by 1lcrV, 1yopB, or ∆yopD
mutants. Of note, the analysis was performed in a1yopK mutant
background as the levels of both hemolysis and translocation,
are known to be highly up-regulated in the absence of YopK
(Holmstrom et al., 1997). These results indicate that the two
LcrV+/−1 strains are unable to induce pore formation. Since
functional LcrV is required for membrane insertion of YopB
and YopD (Broz et al., 2007), we therefore wanted to establish
if these mutants could still localize YopB and YopD to the
cell membrane or not. To this end, membranes from infected
erythrocytes were isolated by floatation on a sucrose gradient and
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FIGURE 1 | The LcrV frameshift variants are non-hemolytic. Sheep
erythrocytes were infected with Y. pseudotuberculosis strains for 2 h in 96-well
plates. The cells were centrifuged and the supernatants collected. The lytic
activity was measured as absorbance at 570 nm and is presented as percent
of complete lysis (erythrocytes lysed with 1% Triton X-100). The results shown
are the mean values ± SD of four independent experiments.
subjected to SDS-PAGE and Western blot analysis using YopB
and YopD antisera. By this approach, we were unable to detect
YopB, and the levels of YopD were very low, in the membranes
of cells infected with the two LcrV+/−1 strains both in parental
background and in the 1yopK mutant background (Figure 2).
As expected (Thorslund et al., 2011), infection with the 1yopK
mutant resulted in increased levels of both YopB and YopD in the
membranes (Figure 2). Control experiments verified that during
infection the total levels of YopB and YopD were similar for all
strains except for the 1lcrV mutant, for which the expression
of the T3SS encoding genes is known to be down-regulated
(Pettersson et al., 1999) (Figure S2). Overall, the phenotype
of the LcrV+/−1 strains was similar to a 1lcrV mutant with
respect to hemolytic activity and membrane insertion of YopB
and YopD. Thus, the LcrV+/−1 strains evidently induced YopE
mediated cytotoxicity, as reported previously (Bröms et al.,
2007), without localizing YopB and YopD to the erythrocyte
membrane.
The LcrV+/−1 Mutants Translocate YopE
and YopH Despite Lack of Hemolytic
Activity
As mentioned above, past studies have shown a strong
correlation between lytic activity due to pore formation and
the functional translocation of T3SS effectors (Håkansson et al.,
1996; Holmstrom et al., 1997; Neyt and Cornelis, 1999; Olsson
et al., 2004; Ryndak et al., 2005). Hence, it was important
to verify that the LcrV+/−1 mutants that lacked hemolytic
activity really had retained translocation ability. In our previous
study we found that these mutants, similar to the wild type
strain, induced rapid cytotoxicity in infected HeLa cells (Bröms
et al., 2007). In this assay very low levels of translocated YopE
are needed for visible cell rounding. Therefore, to detect any
possible translocation deficiency, we repeated the assay using
FIGURE 2 | The extreme N-terminal of LcrV is required for membrane
insertion of YopB and YopD. Sheep erythrocytes were infected with Y.
pseudotuberculosis for 2 h. The cells were lysed and the membranes were
isolated by flotation on a sucrose gradient. Of the resulting membrane fraction,
20 µg total protein was subjected to SDS-PAGE and Western blot. The YopB
antibody recognizes a non-specific upper band that was used as a loading
control, while the lower band is specific for YopB. The experiment was
repeated three times and a representative experiment is shown. The image
has been cropped to facilitate comparison between samples.
different MOIs. At a high MOI (40:1) the wild type strain
induced full cytotoxicity within an hour of infection, while
at a low MOI (2.5:1), full cytotoxicity was delayed until 3–
4 h of infection. Using this approach it was clear that the
LcrV+/−1 strains induced a cytotoxic response with similar
kinetics as the wild type strain (data not shown), even at MOI
2.5. Since cytotoxic response is an indirect measurement of
intracellular targeting of YopE, we decided to confirm more
directly that YopE was translocated by the LcrV+/−1 strains.
To this end, infected HeLa cells were fixed, permeabilized
and incubated with rabbit-anti-YopE antisera followed by
analysis using laser scanning confocal microscopy. YopE specific
staining was detected in cells infected with the LcrV+/−1
mutants as well as in cells infected with the wild type, thereby
confirming the ability of the mutants to translocate YopE
(Figure 3A). Expectantly, no YopE specific staining was observed
in cells infected with the ∆lcrV mutant. To confirm that this
translocation was general and not just specific for YopE, we
also monitored translocation of YopH using a beta-lactamase
reporter system. HeLa cells were infected with Yersinia variants
expressing a YopH-Bla fusion protein. Already after 40min
of infection, translocation of the fusion protein (as visualized
by the blue fluorescence) was observed in a majority of cells
infected with either the wild type or the LcrV+/−1 mutants
(Figure 3B), once again confirming the general ability of the
LcrV+/−1 mutants to translocate Yop effectors into the host
cell. Quantification of the translocated effectors showed that the
LcrV+/−1 mutants translocated YopE and YopH at wild type
levels (Figure 4).
Translocation by the LcrV+/−1 Mutants Is
Regulated by YopK
As previously mentioned, translocation is up-regulated in
absence of YopK, which correlates with larger pores being
formed (Holmstrom et al., 1997). This prompted us to investigate
translocation of Yop effectors by the LcrV+1 and LcrV−1 strains
in the 1yopK mutant background, for which no pore formation
was seen (Figure 1). To address this, HeLa cells infected with
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FIGURE 3 | Pore forming activity does not correlate to translocation ability. (A) Intracellular localization of YopE in HeLa cells after 1.5 h infection was analyzed
with immunostaining. The samples were viewed using laser scanning confocal microscopy and green staining corresponds to YopE, while the HeLa cell membranes
are stained in red. (B) To analyze translocation of YopH, Hela cells were labeled with the FRET substrate CCF4-AM and infected with the indicated strains expressing
YopH-Beta-lactamase fusion protein (YopH-Bla). Images were acquired in a live cell microscope using a longpass filter. Translocation of the Bla-fusion results in a shift
of fluorescence from green to blue. Both experiments were repeated at least three times.
the different Yersinia strains were fractionated, using a well-
established translocation assay (Nordfelth andWolf-Watz, 2001).
The cytosolic proteins were subjected to SDS-PAGE andWestern
blot using monospecific YopE and YopH antisera. As expected,
the 1yopK mutant translocated increased levels of both YopE
and YopH compared to the isogenic wild type strain (Figure 4).
The LcrV+1 and LcrV−1 strains also translocated increased
levels of YopE and YopH in absence of YopK, at the same
level as the 1yopK mutant (Figure 4). No intracellular YopE
and YopH could be detected in cells infected with the 1lcrV
mutant.
Since translocation of effectors occurred although little or no
YopB and YopD could be detected in the erythrocyte membranes
it was important to establish that effector translocation by the
two LcrV+/−1 strains still required YopB and YopD. To address
this, the LcrV+/−1 strains were also mutated for yopB and
yopD. None of these strains were able to induce cytotoxicity of
infected HeLa cells (data not shown) confirming that the effector
translocation observed herein still required functional YopB and
YopD.
It is puzzling that translocation in the LcrV+/−1 strains is
regulated as in the wild type despite the lack of lytic activity.
Contrasting with numerous previous studies, our results show
that neither lytic activity nor translocator insertion in erythrocyte
membranes have any correlation with levels of Yop effector
translocation.
The Non-hemolytic LcrV+/−1 Mutants
Insert YopD into HeLa Cell Membranes
Given the observance of translocation in the absence of lytic
activity, we decided to examine membrane localization of YopB
and YopD in HeLa cells to be consistent with the experimental
setup used in the translocation assays described above. We
found that the levels of YopB were too low to be detected
in cell membranes, regardless of the infecting strain (data not
shown). The levels of YopD were very low, yet detectable
by Western blot, in HeLa cells infected with the wild type
strain (Figure 5). As expected, levels of membrane localized
YopD were higher in cells infected with the 1yopK mutant
background and, most importantly, when the two LcrV+/−1
strains were analyzed in this background both mutants were
found to insert similar levels of YopD into the membranes
as the 1yopK mutant strain (Figure 5). These findings are
very important because above all they verify that using the
erythrocyte model to study T3SS mediated pore formation
and membrane insertion has limitations and can even give
contradictory results that mislead conclusions regarding the
T3SS mechanism. While the erythrocyte model is a convenient
method, the relevance can be questioned, as erythrocytes are not
a natural target cell of Yersinia during infection of an animal
host.
The LcrV N-Terminus Is Involved in
Anti-Phagocytosis and the Intracellular
Targeting of YopH
With the exception of the experiments involving the erythrocyte
infection model, the LcrV+/−1 strains displayed in vitro
phenotypes that were very similar to the parental strain. Based on
these observations, we anticipated that these mutants would be
fully virulent. In order to examine this, we decided to use assays
that could discriminate the impact of these mutations on Yersinia
virulence.
One major virulence mechanism mediated by the T3SS of
Yersinia is the ability to block phagocytosis by professional
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FIGURE 4 | Translocation levels are up-regulated even in the absence
of pore formation. Translocated YopH and YopE detected within HeLa cells
after 1 h of infection (1yopK, 1K/V+1, 1K/V–1 and 1K/1V, 1yopE and
1yopH) or after 2 h (Wt, V+1, V−1, 1lcrV ). Extracellular proteins were
removed by Proteinase K treatment after which the cells were lysed with 1%
Digitonin. One sample (Wt–Digi) was left unlysed as a negative control.
Detection of tubulin served as a loading control. The experiment was repeated
at least three times and a representative experiment is shown. The signal
intensity of the bands was quantified using the Multi Gauge-Image software
(Fujifilm). The values for YopE and YopH were normalized to the loading control
and the ratio ± SEM of translocated Yops relative to the 1yopK mutant, is
shown below each Western blot. The results were analyzed using the paired
Student’s t-test with the significance set at p ≤ 0.01**. NS, No significant
difference.
phagocytes (Rosqvist et al., 1988). To analyze if the LcrV+1
and LcrV−1 strains were affected in the ability to block
phagocytosis we infected J774 macrophages with the different
Yersinia strains for 30min. The cells were then fixed and a
double staining assay was performed to distinguish between
extracellular and internalized bacteria. As expected, the wild type
strain efficiently blocked phagocytosis with only 24% of infecting
bacteria internalized (Figure 6). In contrast, 80% of the infecting
1lcrV mutant and 85% of the virulence plasmid cured strain were
phagocytosed (Figure 6). Interestingly, the LcrV+1 and LcrV−1
strains showed an intermediary phenotype where 41 and 42%
of the bacteria were phagocytosed, respectively (Figure 6). Thus,
even though the LcrV+/−1 strains were able to translocate both
YopE and YopH to levels similar as the wild type strain, some
critical aspect of this translocation process must be compromised
in a manner that causes a significant reduction in phagocytosis
inhibition.
FIGURE 5 | The LcrV mutants promotes insertion of YopD into HeLa
cell membranes. HeLa cells were infected with Y. pseudotuberculosis for 2 h.
The cells were lysed and the membranes isolated by a differential
centrifugation technique. Of the resulting membrane fraction, equal amounts
of total protein were subjected to SDS-PAGE and Western blot. The YopD
antiserum recognized a non-specific band that served as a loading control
(see original figure in Supplementary information, Figure S3). Membrane
preparations of all samples were repeated at least twice. The signal intensity of
the bands was quantified using the Multi Gauge-Image software (Fujifilm) and
normalized to the unspecific band. The ratio ± SEM of YopD relative to the
1yopK mutant, is shown below the Western blot. The results were analyzed
using the paired Student’s t-test with the significance set at p ≤ 0.05*. NS, No
significant difference.
Previous work has established that early targeting of YopH to
focal adhesion complexes is essential for phagocytosis inhibition
(Andersson et al., 1996; Persson et al., 1997, 1999). One of
the YopH targets is Focal Adhesion Kinase (FAK) and it was
shown that the initial phosphorylation of FAK in response
to Yersinia binding to the host cell is quickly reversed by
the powerful phosphatase activity of YopH. By extension, this
deactivation of FAK in turn impairs bacterial uptake (Persson
et al., 1997). Hence, in order to establish if the N-terminal
mutations in LcrV compromised early YopH targeting, we
infected HeLa cells for 10min and then immunoprecipitated
FAK. The phosphorylation level of FAK was analyzed byWestern
blot, using phospotyrosine antibodies. In cells infected with
the YopHC403A strain, FAK remained phosphorylated as this
YopH variant is inactive and cannot dephosphorylate its target
proteins. In contrast, in cells infected with the wild type strain,
only low levels of phosphorylated FAK were detected (Figure 7).
Curiously, the LcrV−1 strain also proved to be less efficient
in blocking the phosphorylation of FAK compared to the
wild type strain. Quantification of the levels of phosphorylated
FAK from three independent experiments indicated a 2.13-
fold reduction of phosphorylated FAK in cells infected with
the wild type strain compared to the YopHC403A strain and
a 1.54-fold reduction when compared to the LcrV−1 strain.
Similar results were also observed with the LcrV+1 strain
(data not shown). Thus, the LcrV+/−1 strains are defective
in early targeting of YopH and this in turn impairs their
ability to block phagocytosis (Figure 6). These are pertinent
findings as they support the notion that LcrV both facilitates
YopB/D localization to the host cell membrane and that the
N-terminal region of LcrV mediates efficient early delivery
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FIGURE 6 | The LcrV N-terminus is required for functional
phagocytosis inhibition. J774.a1 macrophages were infected with
Y. pseudotuberculosis for 30min after which the cells were fixed and
extracellular as well as total bacteria were detected using a double staining
technique. For each sample, the amount of total and extracellular bacteria of
50 infected cells was counted manually using a fluorescence microscope. The
results presented are the mean value ± SEM of five independent experiments.
The result of each experiment was analyzed using the Wilcoxon signed-rank
test and the significance was set at p ≤ 0.01** and p ≤ 0.001***.
of YopH to its molecular targets inside the infected host
cell.
Alterations of the LcrV N-Terminal Results
in Virulence Attenuation In vivo
Since the LcrV+1 and LcrV–1 strains were impaired in anti-
phagocytosis it was necessary to investigate if this correlated to
attenuation in the in vivo mouse infection model. To this end,
C57/BL6 mice were infected intraperitoneally with the various
Yersinia strains. As expected the 1lcrV mutant was completely
attenuated, and all mice survived a high infection dose (1.6× 106
CFU) without displaying any signs of disease (fuzzy fur, diarrhea,
weight loss, listlessness). Mice infected with the wild type strain
showed disease symptoms within a few days even at the lowest
dose used (2.1 × 103 CFU) and all mice had succumbed to
the infection by day 8 post infection. Strikingly, the LcrV+1
and LcrV−1 strains were essentially as attenuated as the 1lcrV
mutant. All but one mouse survived infection with the high
dose of either LcrV+1 or LcrV−1 (Figure 8). Thus, the LcrV+1
and LcrV−1 strains were indeed highly attenuated for virulence,
reflecting that a defect in early targeting of YopH has a dramatic
impact on in vivo virulence.
DISCUSSION
The established role for the translocator LcrV is to facilitate
insertion of YopB and YopD in host cell membranes to promote
FIGURE 7 | Early targeting of translocated YopH is compromised in the
LcrV frameshift mutants. HeLa cells were infected with
Y. pseudotuberculosis for 10min with the indicated strains. The cells were
lysed in RIPA buffer and the lysate was pre-cleared against mouse-IgG and
then incubated with anti-FAK coated beads for 3 h. After washing, the bound
material was eluted in a small volume of sample buffer and all material was
subjected to SDS-PAGE and Western blot using the 4G10 antibody. Images
were acquired in a LAS4000 image reader and the signal intensity was
quantified using Multi Gauge-Image software (Fujifilm). The Western blot image
is one representative experiment and the graph displays the ratio of average
band intensity ± SD from quantification of three independent experiments.
YopH*: YopHC403A. The results were analyzed using the paired Student’s
t-test with the significance set at p ≤ 0.05*. NS, No significant difference.
FIGURE 8 | The LcrV mutants are attenuated for virulence in vivo.
C57/BL6 mice were infected intraperitoneally with Y. pseudotuberculosis at the
indicated doses and signs of disease were monitored daily during 2 weeks.
Mice that showed severe signs of disease, e.g., diarrhea, fussy fur and
listlessness, were humanely sacrificed.
effector translocation (Matteï et al., 2011). Here, we show for
the first time that the very N-terminal part of LcrV also has
a specific role in early targeting of effectors to promote rapid
blockage of phagocytosis in Yersinia. We have characterized two
lcrV mutants that in contrast to the 1lcrV mutant, expressed
and secreted wild type levels of Yop effectors, but were unique
in that they no longer could mediate efficient targeting of YopH
to the focal adhesion sites. As the plasmid encoded T3SS is a
key element in determining an extracellular pathogenic lifestyle
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of Yersinia the targeting defect of these mutants naturally had a
dramatic effect on their in vivo virulence.
LcrV belongs to the class of hydrophilic translocators that
locates to the tip of the needle complex of T3SS (Mueller et al.,
2005). It has been shown that LcrV is required for translocation
and promotes insertion of the two hydrophobic translocators
into the host cell membrane (Pettersson et al., 1999; Broz et al.,
2007). According to the injection model, the needle complex
extends to contact the YopB/YopD induced pore and form a
conduit for direct transport of the effectors from the cytosol of
the bacterium into the host cell. Interestingly, studies from P.
aeruginosa and Shigella indicate an active role of the tip proteins,
PcrV and IpaD respectively, in sensing host cell contact (Lee
et al., 2010; Schiavolin et al., 2013). In addition, it was recently
proposed in P. aeruginosa that a complex of PcrV and the
hydrophobic translocator PopD is involved in sensing host cell
contact (Armentrout and Rietsch, 2016).
In human pathogenic Yersinia spp., LcrV has an additional
regulatory role since 1lcrV mutants are down-regulated for yop
expression (Bergman et al., 1991; Skrzypek and Straley, 1995).
To study the role of LcrV in translocation and virulence, it is
therefore crucial to construct mutants with retained regulatory
competence. Indeed, the two previously characterized lcrV
mutants (LcrV+1 and LcrV−1) with completely altered amino
acid sequences within the first 15 amino acids of the protein
(Figure S1) maintained full control of both expression and
secretion of translocators, including LcrV itself and effectors
(Bröms et al., 2007). In addition, these mutants induced YopE
mediated cytotoxicity on infected HeLa cells, indicating they
retained an ability to translocate into infected cells (Bröms
et al., 2007). When revisiting these mutants we observed that
they were devoid of hemolytic activity and did not insert
YopB or YopD into erythrocyte membrane, not even in a
1yopK mutant background. We could however, confirm that
both the LcrV+1 and the LcrV−1 strain translocated YopE
and YopH at levels indistinguishable from the parental strain
and we also verified that translocation was still dependent on
YopB and YopD. Importantly, we also showed that translocation
by the LcrV+/−1 strains was up-regulated in the absence of
YopK. Collectively, these results show that translocation by
the LcrV+/−1 strains is regulated in the same way as in the
isogenic wild type strain, despite the lack of pore formation
in erythrocytes. Remarkably, when we analyzed YopB/YopD
membrane localization in nucleated cells we found that the
LcrV+/−1 strains inserted similar levels of YopD in the HeLa
cell membranes as the parental strain. Analyzing nucleated cells
is far more challenging compared to erythrocytes and YopB
levels proved to be below the detection limit in the Western blot
analysis. Although we could not verify YopB insertion in HeLa
cell membranes, we find it likely that the LcrV+/−1 strains also
insert YopB along with YopD into the cell membrane. These
results are important as they show that studies of pore formation
in erythrocytes does not necessarily correlate to T3SS activity.
This observation is reinforced by studies on YopD mutants that
had a reduced hemolytic activity but maintained efficient and
functional effector translocation (Costa et al., 2010). Numerous
studies have used erythrocytes as the sole model system to
study pore formation and its role in the T3SS mechanism of
effector translocation across the host cell membrane. Those
studies may need to be revisited to verify the findings in nucleated
cells.
Y. pseudotuberculosis is an extracellular pathogen that
replicates in the lymphatic tissues of the infected animal (Simonet
et al., 1990). Therefore, the anti-phagocytic action mediated
by the plasmid encoded T3SS, in Yersinia, is tremendously
important (Rosqvist et al., 1988). Uptake of bacteria is triggered
immediately after binding of the bacteria to the phagocytic cell.
Hence, to block uptake, Yersinia must rapidly translocate the
effectors upon cell contact. Critically, Andersson et al. have
shown that YopH is rapidly translocated, reaching its eukaryotic
targets within minutes after cell contact (Andersson et al., 1996;
Persson et al., 1999). Here, we first established that the LcrV+1
and LcrV−1 strains translocated YopE and YopH as efficiently
as the wild type strain when measured after 1–2 h of infection.
However, this does not exclude the possibility that these lcrV
mutations may have an effect on the early translocation after
cell contact. Importantly, prolonged measurements of effector
translocation may not always be a true reflection of the T3SS
functional status. This is exemplified by the study of Thorslund
and co-workers, where it was demonstrated that the ability to
induce cytotoxicity did not correlate with the ability to block
phagocytosis (Thorslund et al., 2011). Consistent with this, when
we analyzed the LcrV+1 and LcrV−1 strains for phagocytosis
inhibition, we found that they were significantly impaired in their
ability to block phagocytosis. Together, these data demonstrate
unequivocally that in vitro translocation levels after prolonged
infection do not necessarily predict the outcome of an in vivo
infection.
The YopE and YopH effectors mediate anti-phagocytic
actions through different mechanisms. To block phagocytosis
by macrophages, Yersinia relies heavily on YopH (Fahlgren
et al., 2009), and further it has been shown that YopH is
the effector that has the greatest impact on in vivo virulence
(Logsdon and Mecsas, 2003). YopH is translocated immediately
after cell contact and is actively targeted to the focal adhesion
sites by the T3SS (Thorslund et al., 2011). In line with our
results on phagocytosis inhibition, the early targeting of YopH
to FAK was impaired in the LcrV+/−1 mutants, which suggests
that the inability of the lcrV mutants to block phagocytosis
is due to a defect in the intracellular targeting of translocated
YopH. Thus, despite there being no disparity in the levels
of translocated YopH accumulated after prolonged infection,
by wild type and mutant strains, the early targeting of YopH
was dramatically affected in our mutants. As evidenced from
this work, future studies must recognize the importance of
analyzing translocation at the early time points of infection.
Using our in vivo infection model, LcrV+1 and LcrV−1 strains
were almost fully attenuated for virulence and equivalent to
the non-translocating 1lcrV mutant. Therefore, it seems that
the consequence of inefficient targeting of YopH is as severe
as not being able to translocate at all. In agreement with this,
Persson and co-workers have previously shown that a YopH
variant, which failed to associate YopH with the focal adhesion
sites was strongly reduced in phagocytosis inhibition and was
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also attenuated for virulence in vivo (Persson et al., 1999).
Interestingly, our results show that these lcrV mutations result
in a comparable phenotype.
Based on the results presented here, we propose that LcrV, in
addition to promoting membrane insertion of YopB and YopD,
also has a role in the early targeting of YopH in the eukaryotic
cell. The LcrV+/−1mutations are positioned within a postulated
unstructured region that is somehow recognized for secretion.
This region is not part of the solved LcrV crystal structure
(Derewenda et al., 2004; Chaudhury et al., 2013), and this makes
it difficult to predict what impact the mutations could have on
the overall structure/function of LcrV. However, it is feasible
that it could have some impact on the LcrV/YopD interaction,
which is known to be mediated primarily by the N-terminal
domain immediately downstream of the LcrV+/−1 mutations
(Broz et al., 2007; Armentrout and Rietsch, 2016). This could in
turn have an impact on the cell contact-mediated induction and
effector translocation in line with what was recently proposed
in Pseudomonas (Armentrout and Rietsch, 2016). Considering
the proposed model where YopK directs YopH intracellularly by
bridging RACK1 to the translocon, through YopD (Thorslund
et al., 2011; Dewoody et al., 2013), it is possible that LcrV
via its interaction with YopD impacts on the YopH targeting
efficiency.
It is very intriguing that the LcrV+/−1 mutants, which
initially appeared to possess very subtle phenotypes using
established assays to study T3SS function, in fact turned out
to have a major impact on phagocytosis inhibition and in vivo
virulence. This highlights that for an extracellular pathogen like
Yersinia, it is the early events directly after cell contact that are
crucial for the outcome of the infection. This is very important
since most studies of T3SS secretion and effector translocation
are routinely performed after a few hours of host cell infection.
One obvious reason for this is that protein levels are only readily
detectable at these time points. Yet, our findings clearly signal
that for future research on the molecular mechanism of T3SSs
it is critical to assess the early events after bacteria host cell
contact. We also conclude that using erythrocytes to study pore
formation in relation to T3SS mechanism and function is not




The bacterial strains and plasmids used in this study are
presented in Table 1. Bacteria were routinely grown at 26◦C in
Luria Bertani (LB) agar or LB broth supplemented with 1 mM
CaCl2 and 75mM NaCl. For induction of the T3SS, bacteria
were grown at 37◦C in secretion permissive medium (5mM
EGTA and 20mM MgCl2) (LB–Ca2+) unless otherwise stated.
Where appropriate the following antibiotics were added to the
final concentrations; kanamycin 30 µg/ml, chloramphenicol 25
µg/ml.
HeLa cells were cultivated in Minimum essential medium
(MEM) (Sigma) supplemented with 10% fetal bovine
serum (FBS) (Sigma), 2 mM glutamine, 0.035% sodium
bicarbonate and 100 IU penicillin. J774.1 cells were cultivated in
Dulbecco’s modified eagle medium (DMEM glutaMAX) (Gibco)
supplemented with 10% FBS and 100 IU penicillin. The cells were
kept at 37◦C with 5% CO2. For infection assays cells were seeded
in plates 1 day before experiment and 0.5 hour before infection
the cells were washed and incubated in non-supplemented MEM
or DMEM.
Construction of Mutants
E. coli S17-1 λpir was used to conjugate the suicide plasmids
pJEB368 and pJEB369 into YPIII/pIB155 (1yopK) to generate
1yopK/LcrV+1 and 1yopK/LcrV−1 mutants. 1yopB and
1yopD double mutants were constructed by conjugating the
suicide plasmids pMF024 and pMF463 into YPIIIpIB10201
(LcrV+1) and YPIIIpIB10202 (LcrV−1). The YopH-Bla fusion
was constructed by overlap PCR using the primers listed in
Table S1, yielding a DNA fragment corresponding to codons 6–
468 of YopH fused to beta-lactamase codons 24–286 (Akopyan
et al., 2011). The PCR fragment was cloned into the pcr2.1
TOPO vector (Invitrogen) for amplification, and then sub-cloned
into the pNQ705 suicide vector (Milton et al., 1992). S17-1
λpir was used as the donor strain in conjugation with Yersinia
pseudotuberculosis wild type (YPIII pIB102), LcrV+1 (YPIII
pIB10201) and LcrV−1 (YPIII pIB10202) strains and single
recombination of the pNQ-YopHFL-Bla inactivated the wild type
copy of YopH.
Lytic Activity and Membrane Isolation from
Erythrocytes
Sheep erythrocytes were washed and resuspended in LB–
Ca2+ Supplemented with 75 mM NaCl and Complete Mini
protease inhibitor cocktail (PIC) (Roche). A total of 5 × 109
induced Yersinia bacteria were harvested and resuspended in
5ml erythrocytes suspension (1011 cells) and centrifuged to
create contact between bacteria and cells before incubation at
37◦C. Samples were repeatedly resuspended and centrifuged
during infection to increase contact between bacteria and cells.
After 2 h 100 µL samples were taken and mixed 1:1 with
PBS and centrifuged at 3500 g, 5min, after which 100 µl of
the supernatant was transferred to a flat bottom plate and
the absorbance at 570 nm was measured to determine the
hemolysis.
To analyze total levels of YopB and YopD during infection,
500mL samples were collected, mixed 1:1 with MQ H2O and
vortexed to lyse the cells. The samples were treated with DNAseI
(Thermo Fisher Scientific) according to the manufactures
instructions. The samples were centrifuged at 12,000 g, 5min and
the supernatants were collected and subjected to SDS-PAGE and
Western blot using an antisera which recognizes both YopB and
YopD (ASTI).
To isolate the erythrocytes membranes, 35ml ice-cold lysis
buffer (5mM Tris-HCl, PIC, pH 7.5) was added to the remaining
reactions followed by shaking and incubation on ice 10 min,
then 4.5 ml 10X TBS (200 mM Tris-HCl, 1.5 M NaCl, pH
7.5) was added to restore the pH and salt concentration
and the samples were centrifuged at 3500 g, 20 min. The
supernatants were transferred to thick-wall centrifugation tubes
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TABLE 1 | Strains and plasmids used in this study.
Strains and Plasmids Relevant genotype Reference
Strain
E. coli
S17-1λpir recA, thi, pro, hsdR−M+, SmR, <RP4:2-Tc:Mu:Ku:Tn7>TpR Simon et al., 1983
Y. pseudotuberculosis
YPIIIC Plasmid cured strain Bölin et al., 1982
YPIII pIB102 yadA; Kmr (wild type) Bölin and Wolf-Watz, 1984
YPIII pIB19 pIB102: lcrV full-length in frame deletion; Kmr Pettersson et al., 1999
YPIII pIB155 pIB102: yopK full-length in frame deletion; Kmr Holmstrom et al., 1997
YPIII pIB621 pIB102: yopD full-length in frame deletion; Kmr Olsson et al., 2004
YPIII pIB615 pIB102: yopB full-length in frame deletion; Kmr Bröms et al., 2003
YPIII pIB30 pIB102: yopH full-length in frame deletion; Kmr This study
YPIII pIB526 pIB102: yopE full-length in frame deletion; Kmr Aili et al., 2008
YPIII pIB15519 pIB155: lcrV full-length in frame deletion; Kmr Holmstrom et al., 2001
YPIII pIB10201 pIB102: lcrV +1 frameshift mutation in codons 4–13; Kmr (V+1) Bröms et al., 2007
YPIII pIB10202 pIB102: lcrV −1 frameshift mutation in codons 2–15; Kmr (V−1) Bröms et al., 2007
YPIII pIB1550201 pIB155: lcrV +1; Kmr This study
YPIII pIB1550202 pIB155: lcrV −1; Kmr This study
YPIII pIB6210201 pIB621: lcrV +1; Kmr This study
YPIII pIB6210202 pIB621: lcrV −1; Kmr This study
YPIII pIB6150201 pIB615: lcrV +1; Kmr This study
YPIII pIB6150202 pIB615: lcrV −1; Kmr This study
YPIII pIB102YopH-Bla Wild type, expressing YopHFL-Bla This study
YPIII pIB10201YopH-Bla LcrV +1, expressing YopHFL-Bla This study
YPIII pIB10202YopH-Bla LcrV −1, expressing YopHFL-Bla This study
YPIII pIB102 pYopHC403A Wild type, expressing catalytically inactive YopH This study
Plasmid
pJEB368 pDM4 lcrV + 1 frameshift encompassing codon 4–13 Bröms et al., 2007
pJEB369 pDM4 lcrV −1 frameshift encompassing codon 2–15 Bröms et al., 2007
pMF024 pDM4 yopD full-length in frame deletion Francis and Wolf-Watz, 1998
pMF463 pDM4 yopB full-length in frame deletion Bröms et al., 2003
pDM4-1yopH pDM4 yopH full-length in frame deletion Westermark et al., 2014
pNQ-YopHFL-Bla pNQ705 with YopH1−468-Bla24−286 fusion This study
pYopHC403A Point mutation in the catalytic site of YopH, cloned under its own promoter Persson et al., 1997
(Beckman) and spun at 100,000 g for 2 h at 4◦C. The pellet
was resuspended in 50% sucrose in TBS (20 mM Tris-HCl,
150mM NaCl, PIC, pH 7.5) and sonicated. A step-wise gradient
was established in ultra-clear centrifugation tubes by adding
the resuspended sample on top of 2 ml 65% sucrose-TBS and
overlay with 15ml 44% sucrose-TBS followed by 5ml 25%
sucrose-TBS. Gradients were centrifuged at 15,000 g for 16 h
at 4◦C using a Sw-28 rotor (Beckman). The membranes were
isolated from the 25/44% interface and washed with TBS before
resuspension in 150 µl TBS. The total protein concentration
was estimated in a NanoDrop spectrophotometer at A280 and 20
µg was loaded on a 12% SDS-PAGE and analyzed by Western
blot using YopD polyclonal antisera and YopB monoclonal
antibody.
Intracellular Localization of YopE and YopH
A total of 105 HeLa cells were infected with induced Yersinia
strains at MOI ranging from 2.5:1 to 40:1 and the level of
cytotoxicity was observed in an inverted light microscope,
repeatedly during up to 4 h post infection. For immunostaining
a MOI of 25:1 was used. The cells were washed and fixed in
2% paraformaldehyde after 1.5 h infection. The cell membranes
were stained with TexasRed conjugated wheat germ agglutinin
(Molecular Probes, Invitrogen) before they were permeabilised
in TSB (0.5% Triton X-100 in a buffer consisting of 4%
PEG 6000, 1 mM EGTA and 100 mM Pipes pH 6.8).
Intracellular YopE was detected using an affinity purified
polyclonal YopE antibody followed by an Alexa488-conjugated
secondary antibody (Molecular probes, Invitrogen). The nucleus
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 December 2016 | Volume 6 | Article 175
Ekestubbe et al. The Role of LcrV in Effector Targeting
and bacteria were stained with DAPI. Images were taken with
laser scanning confocal microscopy (Leica).
YopH translocation was analyzed using a beta-lactamase
reporter system (Charpentier and Oswald, 2004; Marketon et al.,
2005) where full length YopH was fused to beta-lactamase. HeLa
cells were seeded in 35 mm glass bottom dishes (MatTek) 1 day
before the experiment. Prior to infection the cells were labeled
with the FRET substrate CCF4-AM (Invitrogen) according to
the manufactures instructions. Induced Yersinia strains were
added to the cells at a MOI of 50:1 and incubated 40min at
room temperature. Images were taken with a live cell microscope
(Nikon Eclipse Ti-E), equipped with a true color camera, using
a long pass filter to detect the two wave length of the FRET
substrate.
Proteinase K Protection Assay
The experiment was performed essentially as described before
(Nordfelth and Wolf-Watz, 2001). In short, 5 × 106 HeLa
cells were infected with induced Yersinia strains at a MOI
of 50:1 in the presence of Cytochalasin D (0.5 µg/ml). After
infection the cells were washed in PBS and treated with 0.5mg/ml
Proteinase K (Roche Diagnostics, Gmbh) for 1min. The cells
were aspirated and incubated 20min at room temperature,
after which, 4 mM PMSF was added to inactivate remaining
Proteinase K. The cells were lysed with 0.4% Digitonin in a
total volume of 1ml. Cell debris and bacteria were pelleted
by centrifugation at 15,000 g, 10min, 4◦C. The supernatant
was separated on a 12% SDS-PAGE and analyzed by Western
blot using affinity purified antisera against YopE and YopH
or monoclonal Tubulin antibody (Sigma Aldrich). The protein
levels were quantified by use of the LAS4000 image reader and
Multi Gauge-Image software (Fujifilm). The levels of YopE and
YopH were normalized against Tubulin levels. The results were
analyzed using the paired Student’s t-test with the significance set
at p ≤ 0.05∗, p ≤ 0.01∗∗ and p ≤ 0.001∗∗∗.
Isolation of Plasma Membrane from HeLa
Cells
A total of 107 HeLa cells were infected in duplicates with Yersinia
strains at aMOI of 50:1 in 15 cm dishes. After 1 h at 37◦C the cells
were put on ice for 5 min and washed twice with ice cold PBS.
The cells were scraped off in 5 mL ice-cold PBS and suspension
from the duplicate dishes were pooled in a centrifugation tube.
The cells were pelleted at 290 g, 5min, resuspended in 1mM
EGTA, 1 mM MgCl2, 1 mM DTT, and incubated on ice for
8min after which the cells were pelleted again at 290 g, 5min.
The cells were resuspended in 0.3 mL 250 mM sucrose, 3 mM
Imidazole and CompleteMini protease inhibitor cocktail (Roche)
(total volume ∼0.4 mL) and lysed by passing 40 times through
a 23 G needle. The lysate was centrifuged at 900 g, 5min and
the supernatant was collected. The pellet was washed with 1 mL
sucrose buffer and spun again at 900 g and the supernatant was
pooled to the previous one and the samples were spun at 14000
g, 5 min. The resulting supernatant was centrifuged at 125000 g
for 1 h using a Ti70.1 rotor (Beckman). The pellet containing
the cell membranes was resuspended in 100 µL 2X SDS loading
buffer. Equal amounts of protein were loaded on a 12% SDS-gel
and analyzed with Western blot using YopD polyclonal antisera.
The levels of YopD were quantified using the Multi Gauge-Image
software (Fujifilm) and normalized to the unspecific band. The
results were analyzed using the paired Student’s t-test with the
significance set at p≤ 0.05∗, p≤ 0.01∗∗ and p≤ 0.001∗∗∗. NS, No
significant difference.
Phagocytosis Inhibition Assay
A total of 105 J774a.1 cells were infected with Yersinia strains
at a MOI of 20:1. After 30min infection unattached bacteria
were washed away with PBS and the cells were fixed in 0.4%
paraformaldehyde. Extracellular bacteria were stained using
Yersinia antisera followed by Alexa568-conjugated antibody
(Molecular Probes, Invitrogen). The cells were permeabilised
with 0.5% Triton X-100 and both extra- and intracellular bacteria
were stained with Yersinia antisera followed by Alexa488-
conjugated antibody (Molecular Probes, Invitrogen). Samples
were viewed in a fluorescence microscope and the total amount
of cell associated bacteria and extracellular bacteria were
counted manually. The results were analyzed using the Wilcoxon
signed-rank test. Each experiment was analyzed separately and
significance was set at p ≤ 0.05∗, p ≤ 0.01∗∗ and p ≤ 0.001∗∗∗.
Immunoprecipitation
A total of 4 × 106 HeLa cells were infected with Yersinia strains
at a MOI of 100:1 in a small volume to create instant contact
between bacteria and cells. The infection was terminated at
different time points by washing two times with ice-cold PBS +
0.1 mM Na3VO4. The cells were lysed in ice-cold precipitation
buffer [50mMTris, 150mMNaCl, 1mMEGTA, 1%Nonidet NP-
40, 0.25% sodium deoxycholate, 1 mM Na3VO4 and Complete
Mini protease inhibitor cocktail (Roche Diagnostics, Gmbh)]
at 4◦C for 20min after which the cells were scraped off and
centrifuged at 16000 g for 10min. The lysate was pre-incubated
with mouse IgG coated protein G Sepharose beads (4 Fast Flow,
Amersham Biosciences, Sweden) at 4◦C for 1 h. The beads were
spun down and the pre cleared lysate was incubated with anti-
FAK (clone 2A7, Upstate Biotechnology, Lake Placid, NY) coated
proteinG sepharose beads at 4◦C for 3 h. The beads were washed
two times in precipitation buffer and the bound material was
eluted in a small volume of 2X SDS loading buffer at 95◦C for
5min. Samples were subjected to SDS-PAGE and the amount
of phosphorylated FAK was analyzed by Western Blot using
a phosphotyrosine antibody (Clone 4G10) (Millipore). Images
were acquired in a LAS4000 image reader and the signal intensity
was quantified usingMulti Gauge-Image software (Fujifilm). The
results were analyzed using the paired Student’s t-test with the
significance set at p≤ 0.05∗, p≤ 0.01∗∗ and p≤ 0.001∗∗∗. NS, No
significant difference.
Mouse Infection Model
Bacteria were grown overnight in unsupplemented LB at
room temperature and harvested and diluted in PBS to final
concentrations ranging from 104to 106 bacteria/ml for the
wild type and LcrV frameshift mutants. The attenuated 1lcrV
mutant was used as a negative control at concentrations 105–107
bacteria/ml. Five C57BL/6 mice were infected intraperitoneally
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with 100 µl for each strain and dilution. Bacteria were plated
on LA plates in parallel to determine the exact infection
dose. The experiments were conducted in accordance with
the ethical permission and all mice were monitored for
symptoms twice daily and mice showing severe symptoms
were sacrificed. Based on our previous experience mice
with severe symptoms normally succumb to the infection
within 24 h. The animal experiment was approved by the
local animal ethics committee at Umea University (Dnr
A144-12).
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